Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Pneumonia × Methylprednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Lymphoma 10 Lymphoma, Non-Hodgkin 9 Lymphoma, Large B-Cell, Diffuse 8 Burkitt Lymphoma 8 Myelodysplastic Syndromes 7 Lymphoma, Follicular 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Multiple Myeloma 6 Leukemia, Myeloid, Chronic-Phase 6 Leukemia, Myeloid, Acute 6 Blast Crisis 6 Lymphoma, Mantle-Cell 5 Lymphoma, B-Cell, Marginal Zone 5 Dendritic Cell Sarcoma, Interdigitating 5 Recurrence 4 Neoplasms, Plasma Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Leukemia, Myelomonocytic, Juvenile 4 Leukemia, Myeloid, Accelerated Phase 4 Hodgkin Disease 4 Graft vs Host Disease 4 Congenital Abnormalities 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Myeloproliferative Disorders 3 Lymphoma, B-Cell 3 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2

Interventions

tocilizumab 1 ceftolozane, tazobactam drug combination 1 Ribavirin 1 Nebulizers and Vaporizers 1 Methylprednisolone 1 Lidocaine 1 Immunoglobulin G 1 Gelsolin 1 Etanercept 1 Disulfides 1 Calcitriol 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

37 enrolled 20 charts

Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡